Rinnovare Labs™

Delaware C-Corporation · Biotechnology and wellness

Specifications, and where the evidence stops.

Rinnovare Labs™ builds and supplies products at the edge of consumer biotechnology — photobiomodulation panels, glutathione supplementation, topicals, and a cell-science programme. We publish what each product is, and we say plainly where the research runs out.

Products

Four products, three regulatory categories

A light-emitting device, a dietary supplement and a topical are governed by different rules, and each carries a different standard of evidence. We keep them separate rather than blending them into one claim.

The Rinnovare R-1000 full-body red light panel standing upright in a dark studio.

Device

Rinnovare™ R-1000 Panel

Eight wavelengths, 1,155 LEDs, 540 W, 72 inches of coverage. Full-body in one session.

$9,995.99

Specifications
The Rinnovare R-100 targeted red light panel on a stand in a dark studio.

Device

Rinnovare™ R-100 Panel

The same spectrum in a targeted format, for a single area rather than the whole body.

$3,995.99

Specifications
The GlutaYouth supplement bottle on a pale surface in soft directional light.

Supplement

GlutaYouth™

350 mg reduced glutathione per capsule in a CyLoc® octadextrin matrix. 60 capsules.

$29.99 60 capsules

Current inventory. Packaging is being updated.

The Rinnovare Labs™ Rejuvenation Gel tube photographed on a pale surface.

Topical

Rejuvenation Gel

A topical gel for daily use, formulated to sit alongside the supplement rather than duplicate it.

$60.00

Biotech

The cell-science programme

Our first biotechnology product is Muse cells — Multilineage-differentiating Stress-Enduring cells, a rare subpopulation resident in adult connective tissue. We work on this with Pilargo Foundation™, which supplies wholesale to licensed clinics and research groups.

This is a different kind of product from a light panel or a capsule, and it is held to a different standard. Muse cell preparations are investigational. No regulator has approved one, anywhere.

What we will not tell you

That Muse cells have been shown to outperform standard mesenchymal therapy in patients. No head-to-head human trial has ever compared them, for any condition.

Position

Why we write it this way

Consumer biotechnology has a credibility problem, and it is self-inflicted. Products arrive wrapped in mechanisms that cannot be measured and benefits that were never tested. Buyers have learned to discount everything, including the parts that are real.

So we publish specifications, we cite the literature where it exists, and we say nothing where it does not. On the panels, that means naming the wavelengths where the evidence is strong and the ones where independent studies are thin. It is a less exciting page. It is the one that survives a customer checking it.